June 22, 2018
A drug product for which Dr. Reddy's is seeking U.S. Food and Drug Administration approval would infringe an Eli Lilly and Co. patent covering best-selling cancer treatment Alimta, an Indiana federal judge found Friday following a bench trial, ruling that the two drug products are equivalent.